Anti-HER2/neu IgG3–(IL-2) and anti-HER2/neu IgG3–(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: Implications in immunotherapy and vaccination strategies
Keywords: BMDC, bone marrow-derived dendritic cells; ECDHER2, extracellular domain of HER2/neu; MIIC, MHC-II compartments; ns, non-specific; DNS, dansyl; OVA, ovalbuminCancer; HER2/neu; Cytokine; Antibody fusion proteins; Immunotherapy